UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2025	Dec. 31, 2024	[1]
CURRENT ASSETS
Cash and cash equivalents	$ 178,589,422	$ 233,318,766
Short-term investments	4,815,376	22,304,829
Accounts receivable, net	384,673,839	295,344,353
Inventories, net	499,243,613	436,497,445
Prepaid expenses and other	101,151,652	49,862,777
Total current assets	1,168,473,902	1,037,328,170
PLANT AND EQUIPMENT—NET	799,496,473	728,481,467
OTHER ASSETS
Goodwill	356,913,957	340,668,927
Long-term investments	247,357,706	339,604,044
Intangible assets, net	191,437,576	195,157,160
Deferred tax asset	92,660,519	53,154,832
Patents and other assets, net	82,414,519	66,426,375
Total other assets	970,784,277	995,011,338
TOTAL ASSETS	2,938,754,652	2,760,820,975
CURRENT LIABILITIES
Accounts payable	252,041,199	168,314,912
Short-term debt	4,130,859	0
Accrued liabilities	138,284,171	84,377,764
Total current liabilities	394,456,229	252,692,676
OTHER NON-CURRENT LIABILITIES	45,097,267	36,028,644
DEFERRED INCOME TAXES	1,666,672	0
TOTAL LIABILITIES	441,220,168	288,721,320
REDEEMABLE NON-CONTROLLING INTEREST	2,319,658	0
SHAREHOLDERS’ INVESTMENT
Common stock	13,137,108	13,632,448
Additional paid-in capital	1,012,857,311	1,010,440,420
Retained earnings	1,471,866,630	1,450,287,128
Accumulated other comprehensive loss	(2,646,223)	(6,409,341)
TOTAL GENTEX CORPORATION SHAREHOLDERS' INVESTMENT	2,495,214,826	2,467,950,655
Non-controlling Interest	0	4,149,000
TOTAL SHAREHOLDERS' INVESTMENT	2,495,214,826	2,472,099,655
TOTAL LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND SHAREHOLDERS' INVESTMENT	$ 2,938,754,652	$ 2,760,820,975

[1] The condensed consolidated balance sheet at December 31, 2024 has been derived from the audited consolidated financial statements at that date, but does not include all of the inflation and footnotes required by accounting principles generally accepted in the United States for complete financial statements.